- Home
- GYRE vs ALX Comparison
GYRE vs ALX Comparison
Compare GYRE & ALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GYRE
- ALX
- Stock Information
- Founded
- GYRE 2002
- ALX 1928
- Country
- GYRE United States
- ALX United States
- Employees
- GYRE N/A
- ALX N/A
- Industry
- GYRE Biotechnology: Pharmaceutical Preparations
- ALX Real Estate Investment Trusts
- Sector
- GYRE Health Care
- ALX Real Estate
- Exchange
- GYRE Nasdaq
- ALX Nasdaq
- Market Cap
- GYRE 990.4M
- ALX 1.1B
- IPO Year
- GYRE N/A
- ALX N/A
- Fundamental
- Price
- GYRE $7.72
- ALX $209.45
- Analyst Decision
- GYRE
- ALX Sell
- Analyst Count
- GYRE 0
- ALX 1
- Target Price
- GYRE N/A
- ALX $125.00
- AVG Volume (30 Days)
- GYRE 221.1K
- ALX 15.6K
- Earning Date
- GYRE 03-17-2025
- ALX 05-05-2025
- Dividend Yield
- GYRE N/A
- ALX 8.56%
- EPS Growth
- GYRE N/A
- ALX N/A
- EPS
- GYRE 0.05
- ALX 8.46
- Revenue
- GYRE $105,757,000.00
- ALX $226,374,000.00
- Revenue This Year
- GYRE $51.85
- ALX N/A
- Revenue Next Year
- GYRE $29.83
- ALX N/A
- P/E Ratio
- GYRE $155.02
- ALX $24.95
- Revenue Growth
- GYRE N/A
- ALX 0.63
- 52 Week Low
- GYRE $7.00
- ALX $184.76
- 52 Week High
- GYRE $19.00
- ALX $251.63
- Technical
- Relative Strength Index (RSI)
- GYRE 33.88
- ALX 47.96
- Support Level
- GYRE $8.65
- ALX $207.89
- Resistance Level
- GYRE $9.50
- ALX $213.00
- Average True Range (ATR)
- GYRE 1.02
- ALX 3.81
- MACD
- GYRE -0.24
- ALX -1.06
- Stochastic Oscillator
- GYRE 12.81
- ALX 20.31
About GYRE Gyre Therapeutics Inc.
Gyre Therapeutics Inc is a biopharmaceutical company headquartered in San Diego, CA, that is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis), formerly known as Nonalcoholic Steatohepatitis (NASH)) in the United States. In the United States, Hydronidone is currently being evaluated for the treatment of liver fibrosis across a broad spectrum of chronic liver diseases under an active Investigational New Drug (IND) application. Gyre is also advancing a diverse pipeline in China through a controlling interest in the Beijing Continent, including pirfenidone, F573, F528, and F230.
About ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.